| Metric | Q4'25 | Q1'26 | Change |
|---|---|---|---|
| Net Interest Margin | Described only qualitatively as having 'held fairly well,' no explicit bps figure given | 420 bps, explicitly cited and compared favorably to peers | First explicit NIM figure given on a call in recent memory |
| Deposit cost management | Praised qualitatively as managing deposit costs with results described as coming in 'very favorably,' no bps figure given | Rates cut 18 bps amid rising competition while still growing deposits | New hard metric, favorable |
| RESG 2027/2028 growth framing | 'we're very optimistic about 2027' | 'RESG may not be a great source of growth in 2027... may be 2028' | 1-year slip in recovery timeline |
| Buyback activity disclosed on call | 2.25M shares repurchased at $44.45 avg, ~$100M authorization left | No mention in Q&A; call concluded without capital-return commentary | Disappeared metric |
| Dividend increase streak | 62nd consecutive quarterly increase | Not mentioned; call concluded without revisiting the streak | Disappeared metric |
| ACL dollar balance | $632M, built up from $300M over the cycle | Not restated by management in response to the NCO question | Dollar figure dropped from management's own language |
| Named distressed RESG credits | 'A handful of sponsors' unable/unwilling to support projects | Explicitly five named loans, with status detail on each (recap LOI, sale processes, land buyer interest) | More granular disclosure, but confirms ongoing bleed |
| CIB pull-through rate | No win-rate/selectivity metric disclosed on the Q4 call; CIB build described only qualitatively | 14-15%, passing on 80-85% of deals seen | New disclosure, no trend to compare |
| Efficiency ratio | Not quantified on the Q4 call; only general commentary on expense build and future noninterest income impact | 39%, expected to stay 'high 30s... this year and maybe into next' | New explicit figure with soft forward guide |
| Indirect lending as % of portfolio | Not addressed specifically on the Q4 call; only broad 2026 outlook given qualitatively | Pushed up to ~13% of portfolio, management noting it 'stayed steady at 12' previously | +100 bps mix shift, still small/high-quality book |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.